NCT05290324View on ClinicalTrials.gov

Propofol or Midazolam for Sedation and Early Extubation Following Coronary Artery Bypass Graft Surgery

NACompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

February 1, 2019

Primary Completion Date

February 1, 2020

Study Completion Date

February 1, 2020

Conditions
Coronary Artery Disease
Interventions
DRUG

Midazolam

Midazolam infusion will be given after the surgery as 0.25 mg/kg/min.

Trial Locations (1)

59341

Ch. Pervaiz Elahi Institute of Cardiology, Multan

All Listed Sponsors
lead

Chaudhry Pervaiz Elahi Institute of Cardiology

OTHER_GOV

NCT05290324 - Propofol or Midazolam for Sedation and Early Extubation Following Coronary Artery Bypass Graft Surgery | Biotech Hunter | Biotech Hunter